Polyphenolic extract association with renin inhibitors in experimental arterial hypertension

Abstract

Various epidemiological studies have shown an inverse association between the consumption of polyphenols or polyphenol-rich foods and the risk of cardiovascular diseases. The purpose of the study was to emphasize the effects of the association between the renin inhibitor and the polyphenolic extract on biochemical parameters and systolic and diastolic blood pressure. The polyphenols are extracted from isolated and purified vegetable material represented by the mature fruit of the Aronia melanocarpa. The experiment was performed on the arterial hypertension model. In the arterial hypertensive model the cardioprotective effects of the polyphenolic extract from Aronia melanocarpa are represented by the antioxidant, hypocolesterolemiant intervention. Polyphenolic extract from Aronia melanocarpa reduce systolic and diastolic arterial tension values in rats with drug-induced hypertension, a phenomenon more pronounced when polyphenols are associated with Aliskiren (renin inhibitor). The combination between the Aliskiren and polyphenolic extract produce superior hypolipidemic and antioxidant effects than in the case of separate administration within experimental arterial hypertension induced in the murine model.

Share and Cite:

Ciocoiu, M. , Badescu, M. , Badulescu, O. , Tutunaru, D. and Badescu, L. (2013) Polyphenolic extract association with renin inhibitors in experimental arterial hypertension. Journal of Biomedical Science and Engineering, 6, 493-497. doi: 10.4236/jbise.2013.64062.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Oszmianski, J. and Wojdylo, A. (2005) Aronia melanocarpa phenolics and their antioxidant activity. European Food Research and Technology, 1, 1-5.
[2] Pascual-Teresa, S. and Sanchez-Ballesta, M.T. (2008) Anthocyanins: From plant to health. Phytochemistry Reviews: Proceedings of the Phytochemical Society of Europe, 7, 281-299.
[3] Mennen, L.I., Sapinho, D. and De Bree, A. (2004) Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women. The Journal of Nutrition, 134, 923-926.
[4] Bell, D.R. and Gochenaur, K. (2006) Direct vasoactive and vasoprotective properties of anthocyanin—Rich extracts. Journal of Applied Physiology, 100, 1164-1170. doi:10.1152/japplphysiol.00626.2005
[5] Yao, L.H., Jiang, Y.M., Shi, J., Tomas-Barberan, F.A., Datta, N. and Singanusong, R. (2004) Flavonoids in food and their health benefits. Plant Foods for Human Nutrition, 59, 113-122.
[6] Lee-Hilz, Y.Y., Boerboom, A.M., Westphal, A.H., Berkel, W.J., Aarts, J.M. and Rietjens I.M. (2006) Pro-oxidant activity of flavonoids induces EpRE mediated gene expression. Chemical Research in Toxicology, 19, 1499-1505. doi:10.1021/tx060157q
[7] Rahman, I., Biswas, S.K. and Kirkham, P.A. (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology, 72, 1439-1452. doi:10.1016/j.bcp.2006.07.004
[8] Hernandez-Montes, E., Pollard, S.E., Vauzour, D., Jofre- Montseny, L., Rota, C. and Rimbach, G. (2006) Activation of glutathione peroxidase via Nrf1 mediates genistein’s protection against oxidative endothelial cell injury. Biochemical and Biophysical Research Communications, 346, 851-859. doi:10.1016/j.bbrc.2006.05.197
[9] Masella, R., Di Benedetto, R., Vari, R., Filesi, C. and Giovannini, C. (2005) Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. The Journal of Nutritional Biochemistry, 16, 577-586. doi:10.1016/j.jnutbio.2005.05.013
[10] Kokotkiewicz, A., Jaremicz, Z. and Luczkiewicz, M. (2010) Aronia plants: A review of traditional use, biological activities, and perspectives for modern medicine. Journal of Medicinal Food, 13, 255-269. doi:10.1089/jmf.2009.0062
[11] Naruszewicz, M., Laniewska, I., Millo, B. and Dluzniewski, M. (2007) Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infarction. Atherosclerosis, 194, e179-e184. doi:10.1016/j.atherosclerosis.2006.12.032

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.